Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUES:
Revenue	$ 125,966	$ 117,985	$ 362,164	$ 345,113
OPERATING EXPENSES:
General and administrative expense, exclusive of depreciation expense shown below	10,001	15,115	29,393	33,246
Depreciation	3,999	4,322	12,572	13,531
Amortization	172	174	516	587
Other (income) expense, net	(1,781)	(1,184)	(62)	(4,222)
OPERATING INCOME (LOSS)	14,645	6,640	25,906	31,062
Interest expense	3,138	2,669	8,489	6,562
Income (loss) from continuing operations before income taxes	11,507	3,971	17,417	24,500
Income tax expense (benefit)	3,856	2,962	4,449	7,068
Income (loss) from continuing operations	7,651	1,009	12,968	17,432
Net income (loss)	7,651	1,009	12,968	17,432
Net income (loss) attributable to non-controlling interest	127	135	266	393
Net income (loss) attributable to Core Laboratories N.V.	$ 7,524	$ 874	$ 12,702	$ 17,039
EARNINGS (LOSS) PER SHARE INFORMATION:
Basic earnings (loss) per share from continuing operations	$ 0.17	$ 0.02	$ 0.28	$ 0.38
Basic earnings (loss) per share attributable to Core Laboratories N.V.	0.16	0.02	0.27	0.37
Diluted earnings (loss) per share from continuing operations	0.16	0.02	0.28	0.37
Diluted earnings (loss) per share attributable to Core Laboratories N.V.	$ 0.16	$ 0.02	$ 0.27	$ 0.36
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	46,338	46,289	46,319	45,932
Diluted (in shares)	47,012	47,125	47,117	46,833
Service [Member]
REVENUES:
Revenue	$ 87,891	$ 84,820	$ 258,036	$ 255,065
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	67,618	67,086	204,641	197,717
Product [Member]
REVENUES:
Revenue	38,075	33,165	104,128	90,048
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	$ 31,312	$ 25,832	$ 89,198	$ 73,192